 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
||||||||||||||
 |
 |
 |
 |
 |
 |
 |
|
||||||||
 |
 |
 |
|
||||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
||||||
 |
 |
 |
 |
|
|||||||||||
CTTE-2012 Program
Links to daily schedule:
Monday • Tuesday • Wednesday • Thursday
Course is scheduled to be held in CLAPP HALL.
Arrive at the Hovorka Atrium, at the center of the Millis Science Center Building,
2080 Adelbert Road Cleveland, OH 44106-7080. (Click here
for a Campus Map to locate the Millis Science Center).
Check-in begins Monday, May 21, 2012 (9:00 a.m. - 12:30 p.m., Hovorka Atrium). Course notebooks, nametags, and other meeting materials will be distributed during the check-in process. Course registrations should be completed as soon as possible via fax or email using the registration form on this site. Registration questions can be answered by emailing Tammie Lee directly at tammie.lee@case.edu.
Monday, May 21, 2012
11:00 a.m.-12:30 p.m. – Registration
SESSION I: Stem Cells
10:00-11:00 a.m. – Introduction to Course:
Adult Mesenchymal Stem Cells: Cell-Based Therapies and Tissue Engineering
Arnold I. Caplan, Ph.D. – Case Western Reserve University
11:00-12:00 a.m.
Cellular Alchemy: Switching Cell Fate or Reprogramming Cell Fate
Paul Tesar, Ph.D. – Case Western Reserve University
12:00-12:45 p.m. - Break – Light Lunch
12:45-1:45 p.m.
Creation of 'Next Generation' Devices for Wound Healing
Ira M. Herman, Ph.D. – Tufts University
1:45-2:45 p.m. – SPONSOR LECTURE
Enabling Cell Culture and Characterization Technologies for Stem Cell Therapy
Robert E. Newman, Jr., Ph.D., R&D Manager, Stem Cells/Advanced Bioprocessing
BD Technologies
2:45-3:00 p.m. - Break
3:00-4:00 p.m.
Use of Stem Cells for the Treatment of MS
Jeffrey A. Cohen, M.D. – Cleveland Clinic
4:00-5:00 p.m. – SPONSOR LECTURE
Placental Cell Therapies: From Concept to Clinic
Stewart Abbot, Ph.D. – Executive Director Stem Cell Research
Celgene Cellular Therapeutics
5:00-6:00 p.m. – CTTE-2011 KEYNOTE LECTURE
Making Liver from Stem Cells?
Catherine Verfaillie, M.D. – Stamcel Instituut, Leuven, Belgium
6:00 p.m. – Dinner Reception, Hovorka Atrium
SESSION II: Scaffolds, Cells and Technology
8:00-9:00 a.m.
The Engineering Interface: Cells and Scaffolds
Antonios Mikos, Ph.D. – Rice University
9:00-10:00 a.m. – SPONSOR LECTURE
New Second Generation Allogeneic Cancellous Bone Matrix Containing Viable MSCs
Raymond J. Linovitz, M.D., F.A.C.S. – Medical Director
Orthofix International, V.V./Blackston
10:00-10:15 a.m. – Break
10:15-11:15 a.m
Magic Gels, Green Cells, and Blood Vessels: Building Environments for Regenerative Medicine
Erin Lavik, Sc.D. – Case Western Reserve University
11:15-12:15 p.m.
Stem Cells Homing: Have a Heart
Mark Penn, M.D., Ph.D. – Summa Cardiovascular Institute
12:15-1:30 p.m. – Lunch
1:30-2:30 p.m.
Stem Cells, DNA Repair, and Longevity
Stanton Gerson, M.D. – Case Western Reserve University
2:30-3:30 p.m.
Marrow-Derived Mesenchymal Stem Cells
Donald Lennon, D.D.S. – Case Western Reserve University
3:30-3:45 p.m. – Break
3:45-6:00 p.m. – MSC Laboratory
Differentiation of MSCs and Selection of Fetal Bovine Serum
Donald Lennon, D.D.S. – Case Western Reserve University
Wednesday, May 23, 2012
SESSION III: Complex Tissues and Stem Cells
8:00-9:00 a.m.
Cardiac Therapies: ES-Cells or ELSE
Loren Field, Ph.D. – Indiana University School of Medicine
9:00-10:00 a.m. – SPONSOR LECTURE
Engineering Scaffolds to Maximize Biological Response
Ann Burgess, Ph.D. – Vice President, Biologics & Extremities R&D
Wright Medical Technology, Inc.
10:00-10:15 a.m. – Break
10:15-11:15 a.m. – SPONSOR LECTURE
Dermagraft® - Therapeutic Opportunities
Conan Young, Ph.D. – Director of R&D, Advanced BioHealing, Inc., a Shire Company
11:15-a.m.-12:15 p.m.
Perivascular Origin of Multipotent Adult Stem Cells
Bruno Péault, Ph.D. – University of California
12:15-1:00 p.m. – Lunch
1:00-2:00 p.m.
Adipose Stem Cells in Angiogenesis, Vasculogenesis and Multi-Organ Tissue Rescue
Keith March, M.D., Ph.D. – Indiana University
2:00-3:00 p.m. – SPONSOR LECTURE
Impact Factor: The Role of Scientific Publishing in the Development of Tissue Engineering
Peter C. Johnson, M.D. – President and CEO
Scintellix, LLC
3:00-3:15 p.m. – Break
3:15-4:15 p.m.
OsteoBlance by Cells and Drugs
Philip Osdoby, Ph.D. – Washington University
4:15-5:15 p.m.
Polymers for Controlled Factor and Cell Release
David Mooney, Ph.D. – Harvard School of Engineering & Applied Science
Meeting Adjourned
Scan this QR-code to send this page to your handheld device
